Evaluating concordance in assessment of ECOG performance status in acute myeloid leukemia patients
Leukemia
.
2022 Oct;36(10):2528-2530.
doi: 10.1038/s41375-022-01664-4.
Epub 2022 Aug 5.
Authors
Nicole Mostofi
1
,
Carole Shaw
2
,
Roland B Walter
2
3
,
Mary-Elizabeth M Percival
4
5
,
Elihu H Estey
2
3
Affiliations
1
University of Washington School of Medicine, Seattle, WA, USA.
2
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
3
Department of Medicine, University of Washington, Seattle, WA, USA.
4
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. mperciva@uw.edu.
5
Department of Medicine, University of Washington, Seattle, WA, USA. mperciva@uw.edu.
PMID:
35931729
DOI:
10.1038/s41375-022-01664-4
No abstract available
MeSH terms
Humans
Leukemia, Myeloid, Acute* / diagnosis
Prognosis
Remission Induction